Your browser doesn't support javascript.
loading
Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation.
Scully, Eileen P; Gandhi, Monica; Johnston, Rowena; Hoh, Rebecca; Lockhart, Ainsley; Dobrowolski, Curtis; Pagliuzza, Amélie; Milush, Jeffrey M; Baker, Christopher A; Girling, Valerie; Ellefson, Arlvin; Gorelick, Robert; Lifson, Jeffrey; Altfeld, Marcus; Alter, Galit; Cedars, Marcelle; Solomon, Ajantha; Lewin, Sharon R; Karn, Jonathan; Chomont, Nicolas; Bacchetti, Peter; Deeks, Steven G.
Afiliação
  • Scully EP; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge.
  • Gandhi M; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts.
  • Johnston R; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Hoh R; Department of Medicine, University of California, San Francisco.
  • Lockhart A; amfAR, The Foundation for AIDS Research, New York, New York.
  • Dobrowolski C; Department of Medicine, University of California, San Francisco.
  • Pagliuzza A; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge.
  • Milush JM; Case Western Reserve University, Cleveland, Ohio.
  • Baker CA; Research Centre, Centre Hospitalier de l'Université de Montréal and Université de Montréal, Quebec, Canada.
  • Girling V; Department of Medicine, University of California, San Francisco.
  • Ellefson A; Department of Medicine, University of California, San Francisco.
  • Gorelick R; Department of Medicine, University of California, San Francisco.
  • Lifson J; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Altfeld M; AIDS and Cancer Virus Program, Leidos Biomedical Research Inc, Frederick National Laboratory for Cancer Research, Maryland.
  • Alter G; AIDS and Cancer Virus Program, Leidos Biomedical Research Inc, Frederick National Laboratory for Cancer Research, Maryland.
  • Cedars M; Heinrich Pette Institut, Hamburg, Germany.
  • Solomon A; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge.
  • Lewin SR; Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco.
  • Karn J; Peter Doherty Institute of Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Chomont N; Peter Doherty Institute of Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Bacchetti P; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
  • Deeks SG; Case Western Reserve University, Cleveland, Ohio.
J Infect Dis ; 219(7): 1084-1094, 2019 03 15.
Article em En | MEDLINE | ID: mdl-30371873
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Viral / RNA Viral / Linfócitos T CD4-Positivos / Infecções por HIV / HIV-1 / Carga Viral Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Viral / RNA Viral / Linfócitos T CD4-Positivos / Infecções por HIV / HIV-1 / Carga Viral Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article